OPHTHALMIC VISCOELASTIC DEVICES MARKET ANALYSIS

Ophthalmic Viscoelastic Devices Market, by Product Type (Dispersive Ophthalmic Viscoelastic Devices, and Cohesive Ophthalmic Viscoelastic Devices), by Application (Cataract Surgery, Glaucoma Surgery, Vitreoretinal Surgery, Corneal Transplantation Surgery, and Others), by Composition (Sodium Hyaluronate, Chondroitin Sulfate, and Hydroxypropyl Methylcellulose), by End User (Ophthalmic Clinics, Hospitals, and Academic and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI2521
Pages :209
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Ophthalmic Viscoelastic Devices Market- Regional Analysis

Based on Region, the global ophthalmic viscoelastic devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold a dominant position in the market, owing to increasing number of product approvals from the U.S. Food and Drug Administration for marketing products in North America. For instance, in May 2016, ALCON LABORATORIES received U.S. FDA approval for its Cellugel(R) Ophthalmic Viscosurgical Device (OVD).

Asia Pacific ophthalmic viscoelastic devices market is expected to witness significant growth during the forecast period owing to rising demand for technologically advanced products for ophthalmological surgery, as well as presence of major manufacturers such as Ophtechnics Unlimited, and Neu Micromed International Pvt. Ltd in the region. For instance, Ophtechnics Unlimited, company based in India, offers OCXYLON – SODIUM HYALURONATE, an ophthalmic viscosurgical device (OVD).